发明名称 INDANILIDINASETILGUANIDIN TERSUBSTITUSI, PROSES PEMBUATANNYA, PENGGUNAANNYA SEBAGAI OBAT-OBATAN ATAU DIAGNOSTIK DAN OBAT-OBATAN YANG MENGANDUNGNYA
摘要 Indanylidineacetylguanidines I <CHEM> and their pharmaceutically acceptable salts wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and X have the meanings given in the claims, are effective inhibitors of the cellular sodium/proton antiport (Na<+>/H<+> exchanger), which, in numerous diseases (essential hypertension, atherosclerosis, diabetes and the like) is also increased in those cells which are readily accessible for measurements, such as, for example, in erythrocytes, platelets or leukocytes.
申请公布号 ID17565(A) 申请公布日期 1998.01.08
申请号 ID19970002422 申请日期 1997.07.14
申请人 HOECHST AKTIENGESELLSCHAFT 发明人 DR. NIROGI VENKATA SATYA RAMAKRISHNA;ARUN KUMAR JAIN;DR. BANSI LAL;DR. RAO VENKATA SATYA VEERABHADRA VADLAMUDI;ANIL VASANTRAO GHAFE;RAVINDRA DATTATRAYA GUFTE;DR. ANDERAS WEICHERT;DR. JAN ROBERT SCHWARK
分类号 A61K31/155;A01N1/00;A61K31/165;A61P3/06;A61P9/00;A61P9/06;A61P9/10;A61P9/12;A61P25/00;A61P43/00;C07C279/22;C07C327/50;C07C327/54;(IPC1-7):C07C279/22;A61K31/16 主分类号 A61K31/155
代理机构 代理人
主权项
地址